Skip to content
SkimSkim home
In deliveryUnited KingdomAdd to pipeline

RMH clonoSEQ® Assay

Awarded to Adaptive Biotechnologies Corporation

Central London Community Healthcare NHS Trust(buyer)

Published
Published 22 December 2025

Tender documents

Skim pulls every file the buyer attaches to this process and extracts the requirements from it.

Documents as they publish

Specification, evaluation criteria, pricing schedules and every requirement — extracted, searchable and mapped to your response.

View tender files

Overview

The Royal Marsden NHS Foundation Trust has awarded a contract worth £1,158,208.33 to Adaptive Biotechnologies Corporation for the provision of the clonoSEQ® assay, a next-generation sequencing–based test for detection and monitoring of minimal residual disease in haematologic malignancies including multiple myeloma, acute lymphoblastic leukaemia, and chronic lymphocytic leukaemia. The contract includes supply of assay kits and reagents, analysis and reporting software, staff training and technical support, consumables delivery, and ongoing maintenance, with the assay meeting MRD sensitivity of 10⁻⁵ or lower, DNA compatibility, clinical guideline recognition, and clonal evolution tracking capability.

Contracting authority

Find the key decision makers

The people who scope, score and sign this contract — names, roles and how to reach them.

Key details

Country
United Kingdom
Status
In delivery
Procedure
Direct
SME suitable
Yes
Published
22 December 2025
Classification (CPV)
Laboratory reagents

Award outcome

Awarded value
£1,158,208
Award date
22 December 2025
Contract period
20 January 2026 → 19 January 2031
Winner
  • Adaptive Biotechnologies Corporation

Contract ending soon? Skim tracks incumbents and flags recompetes early. Start for Free to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract

    30 December 2025

  2. Contract

    22 December 2025

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

How to win this tender

Skim reads the notice and every document attached to it, scores the fit against your company profile for a clear bid or no-bid call, then drafts each answer from your own evidence and past bids. You review, refine and submit — on time, with every requirement covered.

See exactly how Skim’s agents do this →

Comparing platforms? Skim is set against the alternatives for pre-tender intelligence, tender management software and bid management software.

Find tenders like this before your competitors do.

Skim scans every portal daily and scores each tender against your profile. Start for free and see the tenders you are missing.